Liminal BioSciences Inc. Common Shares

LMNL

Valor de mercado US$ 27,6 mi

Sobre: Liminal Biosciences Inc is a clinical stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using our drug discovery platform and a data driven approach. The company has active business operations in Canada and the United Kingdom.

Funcionários: 43